Gobernanza AbbVie Inc.

ABBV

US00287Y1091

Farmacéuticos

Mercado cerrado - NYSE Otros sitios de cotización 22:01:42 13/07/2026			Después del cierre 02:00:00
248,00 ^USD	-0,03 %		246,15	-0,75 %

13/07	ABBVIE INC. : recomendación de compra de BMO Capital	ZM
13/07	ABBVIE INC. : UBS permanece neutral	ZM

Comité Ejecutivo: AbbVie Inc.

Director

Funciones ocupadasDesde

Robert Michael

55 años

Chief Executive Officer

01/07/2024

Perry Siatis

51 años

General Counsel	17/10/2022
Corporate Secretary	17/10/2022

Demetris Crum

45 años

Human Resources Officer

01/08/2017

David Purdue

48 años

Comptroller/Controller/Auditor

01/03/2025

Latif Akintade

Chief Tech/Sci/R&D Officer

01/06/2023

Roopal Thakkar

54 años

Chief Tech/Sci/R&D Officer

01/01/2003

Azita Saleki-Gerhardt

62 años

Chief Operating Officer

01/07/2023

Scott Reents

59 años

Director of Finance/CFO

23/06/2022

Liz Shea

Investor Relations Contact

01/01/2013

Linda Ray

Chief Tech/Sci/R&D Officer

01/03/2024

Composición del Consejo de Administración: AbbVie Inc.

Administrador

ComitésDesde

Robert Michael

55 años

Executive Committee Chair

01/07/2025

Roxanne Austin

65 años

Audit Committee
Executive Committee	21/04/2015
Compensation Committee
Governance Committee
Nominating Committee
Audit Committee Chair	13/05/2021
Finance Committee	13/05/2021
Governance Committee Chair	01/12/2025
Nominating Committee Chair	01/12/2025

Edward Rapp

68 años

Audit Committee	01/01/2013
Governance Committee
Nominating Committee
Compensation Committee	20/08/2021
Audit Committee Chair	20/08/2021

Thomas Freyman

71 años

Executive Committee	08/05/2020
Compensation Committee	08/05/2020
Governance Committee Chair
Nominating Committee Chair

Brett Hart

57 años

Executive Committee	01/01/2016
Governance Committee	01/01/2016
Nominating Committee	01/01/2016
Compensation Committee Chair

Jennifer Davis

54 años

Audit Committee	11/10/2023
Compensation Committee	11/10/2023
Governance Committee	11/10/2023
Nominating Committee	11/10/2023

Melody Meyer

68 años

Audit Committee	01/01/2017
Executive Committee	01/01/2017
Compensation Committee	13/07/2026

Frederick Waddell

72 años

Executive Committee
Compensation Committee
Audit Committee Chair

Thomas Falk

67 años

Governance Committee Chair	02/05/2024
Nominating Committee Chair	02/05/2024
Audit Committee	09/05/2025

Rebecca Roberts

73 años

Governance Committee
Nominating Committee

William Burnside

74 años

Executive Committee
Audit Committee	01/01/2013

Susan Quaggin

62 años

Governance Committee	11/10/2023
Nominating Committee	11/10/2023

Últimos Nombramientos: AbbVie Inc.

04/05	Kyverna Therapeutics, Inc. nombra a Nadia Dac Directora Comercial, con efecto a partir del 4 de mayo de 2026	CI
04/05	Tenax Therapeutics, Inc. nombra a Timothy Healey Director Comercial, con efecto a partir del 4 de mayo de 2026	CI
16/04	Helus Pharma nombra al Dr. Ken Kramer Vicepresidente Senior de Asuntos Médicos, con efecto a partir del 16 de abril de 2026	CI
23/03	ABIVAX Société Anonyme anuncia cambios en su Consejo de Administración y equipo directivo	CI
24/02	N4 Pharma plc anuncia cambios en la dirección general	CI
23/02	IDEAYA Biosciences, Inc. anuncia el nombramiento de la Dra. Theodora (Theo) Ross, M.D., Ph.D., como Directora de Desarrollo	CI
19/02	Artiva Biotherapeutics anuncia el nombramiento de Elaine Sorg en su Consejo de Administración	CI

Más noticias

Antiguos Directivos y Administradores: AbbVie Inc.

Insider

Funciones ocupadas

DesdeHasta

Robert Alpern

Director/Board Member	01/01/2013	08/05/2026
Independent Dir/Board Member	01/01/2013	08/05/2026

Richard Gonzalez

Chief Executive Officer	01/01/2013	01/07/2024
Chairman	01/01/2013	01/07/2025

Glenn Tilton

Director/Board Member	01/01/2013	01/07/2025
Independent Dir/Board Member	01/01/2013	01/07/2025

Tim Richmond

Human Resources Officer

01/01/2013

30/06/2025

Kevin Buckbee

Comptroller/Controller/Auditor

01/03/2023

01/03/2025

Julia Carroll Strom

Corporate Officer/Principal

08/05/2020

01/02/2025

Thomas Hudson

Chief Tech/Sci/R&D Officer	01/07/2019	10/07/2024
Corporate Officer/Principal	01/01/2016	01/07/2019

Jane Woo

Public Communications Contact

01/04/2021

01/04/2024

Katherine Rielly-Gauvin

Corporate Officer/Principal

01/01/2013

01/07/2023

Brian Durkin

Comptroller/Controller/Auditor	01/01/2016	01/03/2023
Corporate Officer/Principal	01/03/2023	30/06/2023

Frank Benenati

Public Communications Contact

01/04/2021

01/04/2023

Henry Gosebruch

Corporate Officer/Principal

01/12/2015

01/02/2023

Chris Boone

Corporate Officer/Principal

02/01/2023

Mohamed Zaki

Corporate Officer/Principal

01/09/2018

01/12/2022

Michael Severino

Chief Tech/Sci/R&D Officer	01/06/2014	17/12/2018
President	17/12/2018	31/05/2022

Edward Liddy

Director/Board Member	01/01/2013	11/05/2022
Independent Dir/Board Member	01/01/2013	11/05/2022

Kate C. Liebelt

Corporate Officer/Principal

01/06/2020

30/04/2022

Todd D. Bosse

Investor Relations Contact

01/12/2021

Nataskia Lampe

Corporate Officer/Principal

01/03/2012

01/08/2021

Carlos Alban

Director/Board Member	17/12/2018	01/03/2021
Corporate Officer/Principal	01/01/2013	01/03/2021

Karen Hale

Compliance Officer

01/01/2021

Jose-Carlos Gutiérrez-Ramos

Corporate Officer/Principal

01/02/2020

01/01/2021

Adelle Infante

Public Communications Contact

01/12/2020

Janet Hammond

Corporate Officer/Principal

01/11/2016

01/08/2020

Ronald O. Robison

General Counsel	14/01/2013	-
Corporate Officer/Principal	-	01/04/2020

Vusi Moyo

Public Communications Contact

01/04/2020

Myra Rosario Herrle

Corporate Officer/Principal

01/08/2014

01/03/2020

Frank A. Jaeger

Sales & Marketing

01/01/2014

01/08/2019

Nadia Dac

Corporate Officer/Principal

01/12/2014

01/03/2019

Scott Brun

Corporate Officer/Principal

01/03/2019

John Westwater

Director/Board Member

01/04/2018

31/12/2018

Jim Sullivan

Private Equity Investor

01/01/2013

01/12/2018

Graig Suvannavejh

Corporate Officer/Principal

01/03/2017

01/07/2018

Elizabeth Thompson

Chief Tech/Sci/R&D Officer

01/09/2015

01/05/2018

Gary Gordon

Corporate Officer/Principal

01/01/2013

01/04/2018

Paul Schwichtenberg

Corporate Officer/Principal

01/10/2013

01/04/2018

Mark Stenhouse

Corporate Officer/Principal

01/10/2016

01/03/2018

Sujay Kango

Corporate Officer/Principal

01/01/2017

01/02/2018

Shao Lee Lin

Corporate Officer/Principal

01/04/2015

01/12/2017

Thomas A. Hurwich

Comptroller/Controller/Auditor

28/02/2017

Sharon Curran

Corporate Officer/Principal

01/01/2012

01/01/2017

Francisco Velasco

Corporate Officer/Principal

01/06/2009

01/06/2016

Roy S. Roberts

Director/Board Member	01/01/2013	06/05/2016
Independent Dir/Board Member	01/01/2013	06/05/2016

Renee Tannenbaum

Corporate Officer/Principal

01/10/2012

01/01/2016

Rita Jain

Corporate Officer/Principal

01/01/2013

01/01/2016

Maria Rivas

Chief Tech/Sci/R&D Officer

01/08/2012

01/12/2015

Peter Heerma

Corporate Officer/Principal

01/12/2012

01/11/2015

David H. Donabedian

Corporate Officer/Principal

01/08/2015

Paul Wierbicki

General Counsel

01/03/2014

01/05/2015

Jennifer Smoter

Public Communications Contact

01/08/2012

01/03/2015

Barry Regan

Chief Operating Officer	01/01/2013	01/03/2015
Corporate Officer/Principal	-	-

Gary Winer

Corporate Officer/Principal

01/04/2014

01/01/2015

Alysa Spittle

Public Communications Contact

01/01/2013

01/01/2015

Steven N. Gersten

Compliance Officer

01/01/2015

John Leonard

Chief Tech/Sci/R&D Officer

01/01/2013

01/01/2014

Lars Kielhorn

Corporate Officer/Principal

01/01/2011

01/01/2014

Lily Chang

Private Equity Analyst

01/01/2013

01/01/2014

Donald Frail

Corporate Officer/Principal

01/01/2014

Jose Rivera

Compliance Officer

01/01/2013

01/09/2013

George Avgerinos

Corporate Officer/Principal

01/07/2008

01/07/2013

Laura Schumacher

General Counsel	01/01/2013	-
Corporate Secretary	10/02/2014	17/10/2022

Greg W. Linder

Director/Board Member

31/12/2012

Sharon Greenlees

Investor Relations Contact	01/01/2016	01/01/2018
Corporate Officer/Principal	01/01/2018	-

Derrell Porter

Sales & Marketing

Barbara McGovern

Corporate Officer/Principal

Björn Cochlovius

Corporate Officer/Principal

Christopher Kurtz

Corporate Officer/Principal

Ann Tomlin

Human Resources Officer

Gregory Miley

Public Communications Contact	-	-
General Counsel	-	-

Larry Peepo

Investor Relations Contact

Karl G. Trass

Corporate Officer/Principal

Denelle Waynick

General Counsel

Star Seyedkazemi

Corporate Officer/Principal

Li Malmberg

Corporate Officer/Principal

James P. Sullivan

Corporate Officer/Principal

Douglas Feltner

Corporate Officer/Principal

Paulo Vega

Corporate Officer/Principal

William Chase

Chief Administrative Officer	19/10/2018	-
Director of Finance/CFO	-	19/10/2018

Youssef Bennani

Corporate Officer/Principal

David Laskow-Pooley

Director/Board Member

Kimberly Davis-Wells

Corporate Officer/Principal

Glenn S. Warner

Corporate Officer/Principal

Saeed Motahari

Corporate Officer/Principal

Jordan Dubow

Corporate Officer/Principal

Gentry Lassiter

Public Communications Contact

Distribución por Edad de los Ejecutivos

Paridad de género

Hombre	19
Mujer	7

De los cuales Comité Ejecutivo

Hombre	8
Mujer	2

De los cuales Directores

Hombre	8
Mujer	4

Revisiones

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

AbbVie Inc. se especializa en la investigación y el desarrollo de fármacos terapéuticos. Sus productos están destinados al tratamiento de la artritis reumatoide, la psoriasis, la enfermedad de Crohn, las enfermedades tiroideas, la enfermedad de Parkinson, el VIH, las complicaciones de la mucoviscidosis, los niveles bajos de testosterona y las complicaciones asociadas a la enfermedad renal crónica. Las ventas netas se distribuyen geográficamente de la siguiente manera: Estados Unidos (76,2 %), Alemania (2,8 %), Japón (2,1 %), Canadá (2 %), China (1,6 %), Francia (1,3 %), Reino Unido (1 %), España (1 %), Italia (0,9 %), Brasil (0,8 %), Australia (0,8 %) y otros (9,5 %).

Empleados

57.000

Sector

Farmacéuticos

Agenda

15/07 - Fecha ex dividendo - 1.73 USD

Más información sobre la empresa